Inovio Pharmaceuticals, Inc.
INO Real Time Price USDRecent trades of INO by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Chris Jacobs House / R | Sale $1,001 - $15,000 | Sep 08, 2020 |
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by INO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$10,000 Jul 16, 2024 Issue: None
-
$20,000 Apr 22, 2024 Issue: None
-
$50,000 Oct 20, 2023 Issue: Health Issues
-
$60,000 Jul 18, 2023 Issue: Health Issues
-
$130,000 Jan 20, 2023 Issue: Health Issues
-
$140,000 Oct 20, 2022 Issue: Health Issues
-
$140,000 Jul 20, 2022 Issue: Budget/Appropriations Health Issues
-
$150,000 Apr 20, 2022 Issue: Budget/Appropriations Health Issues
-
$60,000 Jan 20, 2022 Issue: Budget/Appropriations Health Issues Defense
-
$30,000 Jan 14, 2022 Issue: Health Issues
-
$60,000 Oct 20, 2021 Issue: Health Issues Defense Budget/Appropriations
-
$30,000 Oct 14, 2021 Issue: Health Issues
-
$60,000 Jul 20, 2021 Issue: Health Issues Defense Budget/Appropriations
-
$30,000 Jul 14, 2021 Issue: Health Issues
-
$60,000 Apr 26, 2021 Issue: Health Issues Budget/Appropriations Defense
-
$30,000 Apr 22, 2021 Issue: Health Issues
-
$30,000 Jan 11, 2021 Issue: Health Issues
-
$30,000 Oct 18, 2020 Issue: Health Issues
-
$30,000 Jul 07, 2020 Issue: Health Issues
-
$10,000 Jan 21, 2020 Issue: Pharmacy
-
$30,000 Oct 14, 2019 Issue: Pharmacy
-
$30,000 Jul 12, 2019 Issue: Pharmacy
-
$30,000 Apr 17, 2019 Issue: Pharmacy
-
$30,000 Jan 08, 2019 Issue: Pharmacy
-
$30,000 Oct 09, 2018 Issue: Pharmacy
-
$30,000 Jul 18, 2018 Issue: Pharmacy
-
$30,000 May 23, 2018 Issue: Pharmacy
-
$30,000 Jan 10, 2018 Issue: Pharmacy
-
$30,000 Oct 12, 2017 Issue: Pharmacy
-
$30,000 Jul 14, 2017 Issue: Pharmacy
-
$10,000 Apr 20, 2017 Issue: Pharmacy
Estimated quarterly lobbying spending
INO Revenue by Segment or Geography
New patents grants
-
Patent Title: Minimally invasive dermal electroporation device Mar. 18, 2025
-
Patent Title: Cancer vaccines targeting boris and uses thereof Dec. 10, 2024
-
Patent Title: Oral mucosal electroporation device and use thereof Oct. 29, 2024
-
Patent Title: Cap for a hand-held electroporation device Sep. 10, 2024
-
Patent Title: Cancer vaccines targeting survivin and uses thereof Aug. 20, 2024
-
Patent Title: Intradermal jet injection electroporation Aug. 06, 2024
-
Patent Title: Cancer vaccines targeting mesothelin and uses thereof May. 21, 2024
-
Patent Title: Cap for a hand-held electroporation device Apr. 30, 2024
-
Patent Title: Electroporation device with detachable needle array with lock-out system Jan. 30, 2024
-
Patent Title: Cancer vaccines and methods of treatment using the same Oct. 31, 2023
-
Patent Title: Vaccines for recurrent respiratory papillomatosis and methods of using the same Sep. 05, 2023
-
Patent Title: Intradermal injection device Aug. 15, 2023
-
Patent Title: Method and device for minimally invasive in vivo transfection of adipose tissue using electroporation Jun. 27, 2023
-
Patent Title: Vaccines against coronavirus and methods of use May. 30, 2023
-
Patent Title: Hand-held electroporation device May. 23, 2023
-
Patent Title: Tolerable and minimally invasive skin electroporation device Jan. 31, 2023
-
Patent Title: Electroporation device and injection apparatus Oct. 18, 2022
-
Patent Title: Cancer vaccines targeting prame and uses thereof May. 24, 2022
-
Patent Title: Cancer vaccines targeting lemd1 and uses thereof May. 24, 2022
-
Patent Title: Device and method for single-needle in vivo electroporation May. 17, 2022
-
Patent Title: Minimally invasive dermal electroporation device Apr. 05, 2022
-
Patent Title: Electroporation device having a battery pack with power switch Apr. 05, 2022
-
Patent Title: Cancer vaccines targeting muc16 and uses thereof Feb. 01, 2022
-
Patent Title: Cancer vaccines targeting mesothelin and uses thereof Oct. 26, 2021
-
Patent Title: Cancer vaccines targeting boris and uses thereof Oct. 26, 2021
-
Patent Title: Multiple tissue layer electroporation applicator and device Aug. 24, 2021
-
Patent Title: Electroporation device with detachable needle array with lock-out system Jul. 27, 2021
-
Patent Title: Intradermal jet injection electroporation device Jun. 08, 2021
-
Patent Title: Cancer vaccines and methods of treatment using the same May. 18, 2021
-
Patent Title: Oral mucosal electroporation device and use thereof Feb. 02, 2021
-
Patent Title: Miniminally invasive dermal electroporation device Jun. 02, 2020
-
Patent Title: Vaccines for human papilloma virus and methods for using the same Mar. 19, 2019
-
Patent Title: Vaccines for human papilloma virus and methods for using the same Mar. 12, 2019
-
Patent Title: Wt1 vaccine Mar. 05, 2019
-
Patent Title: Oral mucosal electroporation device and use thereof Nov. 13, 2018
-
Patent Title: Dna antibody constructs and method of using same Oct. 02, 2018
-
Patent Title: Vaccines having an antigen and interleukin-23 as an adjuvant Jun. 06, 2017
-
Patent Title: Cross-protective arenavirus vaccines and their method of use Sep. 20, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Recent insights relating to INO
Recent picks made for INO stock on CNBC
ETFs with the largest estimated holdings in INO
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $INO stock a Buy, Sell, or Hold?
- What is the price target for $INO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $INO stock?
- Who owns the most shares of $INO stock?
- What funds own $INO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view INO Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.